학술논문

Ocrelizumab-treated patients with relapsing multiple sclerosis show volume loss rates similar to healthy aging
Document Type
Article
Source
In: Multiple Sclerosis Journal. (Multiple Sclerosis Journal, May 2023, 29(6):741-747)
Subject
Language
English
ISSN
14770970
13524585